Filing Details

Accession Number:
0000908834-25-000043
Form Type:
13G Filing
Publication Date:
2025-02-04 19:00:00
Filed By:
Farallon Capital Partners, L.P.
Company:
Elevation Oncology Inc.
Filing Date:
2025-02-05
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Farallon Capital Partners, L.P. 0 733,600 1.2%
Farallon Capital Institutional Partners, L.P. 0 651,700 1.1%
Farallon Capital Institutional Partners II, L.P. 0 204,700 0.3%
Farallon Capital Institutional Partners III, L.P. 0 65,997 0.1%
Four Crossings Institutional Partners V, L.P. 0 130,200 0.2%
Farallon Capital Offshore Investors II, L.P. 0 1,253,085 2.1%
Farallon Capital F5 Master I, L.P. 0 404,300 0.7%
Farallon Capital (AM) Investors, L.P. 0 83,900 0.1%
Farallon Partners, L.L.C. 0 3,123,182 5.3%
Farallon Institutional (GP) V, L.L.C. 0 130,200 0.2%
Farallon F5 (GP), L.L.C. 0 404,300 0.7%
Dapice Joshua J. 0 3,527,482 6%
Dreyfuss, Philip D. 0 3,527,482 6%
Dunn Hannah E. 0 3,527,482 6%
Fried, Richard B 0 3,527,482 6%
Gehani, Varun N. 0 3,527,482 6%
Giauque, Nicolas 0 3,527,482 6%
Kim, David T. 0 3,527,482 6%
Linn, Michael G. 0 3,527,482 6%
Luo Patrick (Cheng) 0 3,527,482 6%
Patel, Rajiv A. 0 3,527,482 6%
Roberts, Jr., Thomas G. 0 3,527,482 6%
Saito Edric C. 0 3,527,482 6%
Seybold, William 0 3,527,482 6%
Short Daniel S. 0 3,527,482 6%
Spokes, Andrew J. M. 0 3,527,482 6%
Warren, John R. 0 3,527,482 6%
Wehrly, Mark C. 0 3,527,482 6%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Farallon Capital Partners, L.P.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:02/05/2025
 
Farallon Capital Institutional Partners, L.P.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:02/05/2025
 
Farallon Capital Institutional Partners II, L.P.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:02/05/2025
 
Farallon Capital Institutional Partners III, L.P.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:02/05/2025
 
Four Crossings Institutional Partners V, L.P.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Manager of its General Partner
Date:02/05/2025
 
Farallon Capital Offshore Investors II, L.P.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:02/05/2025
 
Farallon Capital F5 Master I, L.P.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Manager of its General Partner
Date:02/05/2025
 
Farallon Capital (AM) Investors, L.P.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:02/05/2025
 
Farallon Partners, L.L.C.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member
Date:02/05/2025
 
Farallon Institutional (GP) V, L.L.C.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Manager
Date:02/05/2025
 
Farallon F5 (GP), L.L.C.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Manager
Date:02/05/2025
 
Dapice Joshua J.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Dreyfuss, Philip D.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Dunn Hannah E.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn
Date:02/05/2025
 
Fried, Richard B
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Gehani, Varun N.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Giauque, Nicolas
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Kim, David T.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Linn, Michael G.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Luo Patrick (Cheng)
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Patel, Rajiv A.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Roberts, Jr., Thomas G.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Saito Edric C.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Seybold, William
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Short Daniel S.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Spokes, Andrew J. M.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Warren, John R.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
 
Wehrly, Mark C.
 
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:02/05/2025
Exhibit Information

Exhibit 1. Joint Acquisition Statement Pursuant to Section 240.13d-1(k)